Medicare Enrolled

Dr. Anthonette Sparman, M.D.

Neurology · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2279 CONEY ISLAND AVE, Brooklyn, NY 11223
7189989890
In practice since 2012 (14 years)
NPI: 1598027682 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sparman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sparman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sparman

Dr. Anthonette Sparman is a neurology specialist in Brooklyn, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Sparman performed 259 Medicare services across 198 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sparman received a total of $8,461 from 62 pharmaceutical and/or device companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sparman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 259 Medicare services $8,461 industry payments

Medicare Practice Summary

Medicare Utilization ↗
259
Medicare services
Bottom 35% in NY for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
198
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
92 $91 $150
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $81 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
33 $106 $143
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
31 $160 $300
Complete ultrasound of brain blood flow
An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation.
24 $259 $350
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
22 $149 $300
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $106 $145
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,461
Total received (2018-2024)
Avg $1,209/year across 7 years
Top 26% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
438
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,362 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$500
2023
$872
2022
$1,623
2021
$1,514
2020
$704
2019
$1,132
2018
$2,115

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$146
AstraZeneca Pharmaceuticals LP
$64
Novartis Pharmaceuticals Corporation
$61
Biogen, Inc.
$54
Amgen Inc.
$43
Mallinckrodt Hospital Products Inc.
$32
ARGENX US, INC.
$31
Eisai Inc.
$24
Celgene Corporation
$24
VERTEX PHARMACEUTICALS INCORPORATED
$21
Top 3 companies account for 54.2% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$683
Biogen, Inc.
$625
Eisai Inc.
$607
GENZYME CORPORATION
$475
UCB, Inc.
$438
ABBVIE INC.
$435
US WorldMeds, LLC
$386
Mallinckrodt Hospital Products Inc.
$295
Daiichi Sankyo Inc.
$291
AstraZeneca Pharmaceuticals LP
$250
Neurelis, Inc.
$245
Acorda Therapeutics, Inc
$212
Akcea Therapeutics, Inc.
$205
Lilly USA, LLC
$203
Amgen Inc.
$186
Adamas Pharmaceuticals, Inc.
$180
Vanda Pharmaceuticals Inc.
$176
Celgene Corporation
$165
PFIZER INC.
$162
Purdue Pharma L.P.
$143
Alexion Pharmaceuticals, Inc.
$142
ACADIA Pharmaceuticals Inc
$139
E.R. Squibb & Sons, L.L.C.
$137
Grifols USA, LLC
$126
Merck Sharp & Dohme Corporation
$107
Mallinckrodt LLC
$88
Neurocrine Biosciences, Inc.
$79
Lundbeck LLC
$69
Shionogi Inc
$68
Philips Electronics North America Corporation
$65
Teva Pharmaceuticals USA, Inc.
$62
Novartis Pharmaceuticals Corporation
$61
Pernix Therapeutics Holdings, Inc.
$61
Allergan, Inc.
$61
Kowa Pharmaceuticals America, Inc.
$55
Forte Bio-Pharma LLC
$51
Supernus Pharmaceuticals, Inc.
$50
Horizon Therapeutics plc
$49
Nevro Corp.
$44
Alnylam Pharmaceuticals Inc.
$44
Avanir Pharmaceuticals, Inc.
$43
EISAI INC.
$40
Vertical Pharmaceuticals, LLC
$36
Bausch Health US, LLC
$35
Amneal Pharmaceuticals LLC
$35
Mallinckrodt Enterprises LLC
$31
Biohaven Pharmaceuticals, Inc.
$31
ARGENX US, INC.
$31
Kyowa Kirin, Inc.
$29
RedHill Biopharma Inc.
$23
IBSA Pharma Inc.
$23
LivaNova USA, Inc.
$21
VERTEX PHARMACEUTICALS INCORPORATED
$21
CSL Behring
$21
MDD US Operations, LLC
$20
Iroko Pharmaceuticals, LLC
$17
Cumberland Pharmaceuticals, Inc.
$17
Almatica Pharma LLC
$17
IDORSIA PHARMACEUTICALS US INC
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Aprecia Pharmaceuticals, LLC
$14
Hikma Pharmaceuticals USA
$12
Top 3 companies account for 22.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AJOVY · AMPYRA · AMYVID · APOKYN · AUBAGIO · AUSTEDO · Aimovig · BELSOMRA · BOTOX · BRILINTA · Briviact · EMGALITY · FANAPT · Fycompa · GOCOVRI · Gamunex-C · HETLIOZ · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KRISTALOSE · Kloxxado · LEMTRADA · LEQEMBI · LUCEMYRA · LYRICA · Leqembi · Licart · MIGRANAL · MOVANTIK · MYOBLOC · Morphabond ER · Movantik · NALOCET · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · ONPATTRO · OXTELLAR XR · Omnia · Ongentys · PANZYGA · QULIPTA · QUVIVIQ · RELEXXII · RYTARY · SEGLENTIS · SOLIRIS · SYMPROIC · Seglentis · Senza · Soliris · Spritam · Symproic · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trilogy 100 · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIVLODEX · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · XADAGO · Xadago · ZEPOSIA · ZOHYDRO ER · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Brooklyn?
Compare neurologists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
1,196
Per 100K population
45.2
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sparman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sparman experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Sparman performed 92 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sparman receive payments from pharmaceutical companies?
Yes. Dr. Sparman received a total of $8,461 from 62 companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sparman's costs compare to other neurologists in Brooklyn?
Dr. Sparman's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sparman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →